V. Mutri

841 total citations
22 papers, 620 citations indexed

About

V. Mutri is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, V. Mutri has authored 22 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 7 papers in Gastroenterology. Recurrent topics in V. Mutri's work include Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (14 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). V. Mutri is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (14 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). V. Mutri collaborates with scholars based in Italy, Malaysia and Germany. V. Mutri's co-authors include Andrea Martoni, Carmine Pinto, Fabiola Lorena Rojas Llimpe, Francesca Di Fabio, S. Giaquinta, Stefano Cascinu, Salvatore Siena, S Tanneberger, Laura Giannetta and C. Funaioli and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

V. Mutri

22 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Mutri Italy 9 425 421 189 115 63 22 620
Willemieke P.M. Dijksterhuis Netherlands 12 171 0.4× 215 0.5× 199 1.1× 32 0.3× 40 0.6× 30 463
M Canto United States 5 334 0.8× 213 0.5× 273 1.4× 29 0.3× 17 0.3× 9 477
S. Pugh United Kingdom 14 260 0.6× 98 0.2× 144 0.8× 57 0.5× 15 0.2× 36 506
Jenn Hian Koo Australia 9 205 0.5× 82 0.2× 179 0.9× 132 1.1× 24 0.4× 16 430
Lea Choung Wong Singapore 10 140 0.3× 192 0.5× 182 1.0× 34 0.3× 9 0.1× 15 422
Shaesta Mehta India 10 163 0.4× 159 0.4× 199 1.1× 24 0.2× 13 0.2× 28 319
Elizabeth Won United States 10 172 0.4× 130 0.3× 92 0.5× 29 0.3× 10 0.2× 22 307
Narayan Rajan United States 10 234 0.6× 228 0.5× 75 0.4× 15 0.1× 16 0.3× 21 422
M Meehan United Kingdom 4 415 1.0× 712 1.7× 402 2.1× 172 1.5× 4 0.1× 5 806
Jewel Samadder United States 11 437 1.0× 252 0.6× 144 0.8× 10 0.1× 20 0.3× 25 562

Countries citing papers authored by V. Mutri

Since Specialization
Citations

This map shows the geographic impact of V. Mutri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Mutri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Mutri more than expected).

Fields of papers citing papers by V. Mutri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Mutri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Mutri. The network helps show where V. Mutri may publish in the future.

Co-authorship network of co-authors of V. Mutri

This figure shows the co-authorship network connecting the top 25 collaborators of V. Mutri. A scholar is included among the top collaborators of V. Mutri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Mutri. V. Mutri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martoni, Andrea, Barbara Melotti, V. Mutri, et al.. (2017). Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO study. ESMO Open. 2(1). e000116–e000116. 3 indexed citations
2.
Mutri, V., Carmine Pinto, S. Giaquinta, et al.. (2011). Phase I study of sorafenib and cisplatin/pemetrexed regimen in untreated malignant pleural mesothelioma (MPM) patients: Italian SoMe Study.. Journal of Clinical Oncology. 29(15_suppl). 7087–7087. 2 indexed citations
3.
Pinto, Carmine, Andrea Ardizzoni, Pier Giacomo Betta, et al.. (2010). Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 34(1). 99–109. 15 indexed citations
4.
5.
Cennamo, Vincenzo, Lorenzo Fuccio, V. Mutri, et al.. (2009). Does Stent Placement for Advanced Colon Cancer Increase the Risk of Perforation During Bevacizumab-Based Therapy?. Clinical Gastroenterology and Hepatology. 7(11). 1174–1176. 60 indexed citations
6.
Pinto, Carmine, Francesca Di Fabio, Carlo Barone, et al.. (2009). Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study). British Journal of Cancer. 101(8). 1261–1268. 113 indexed citations
7.
8.
Fabio, Francesco Di, Giorgio Ercolani, Emanuela Giampalma, et al.. (2009). 6087 Prospective comparative study on pre-operative diagnostic accuracy of different imaging techniques in colorectal cancer patients with liver metastases candidates to surgical resection (Italian PROMETEO Study). European Journal of Cancer Supplements. 7(2). 348–348. 1 indexed citations
9.
10.
Fabio, Francesca Di, Carmine Pinto, C. Barone, et al.. (2008). Cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (italian phase II docetux study). CINECA IRIS Institutial research information system (University of Pisa). 5 indexed citations
11.
Fabio, Francesca Di, Carmine Pinto, S. Giaquinta, et al.. (2008). Predictive value of circulating VEGF in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma treated with cetuximab in combination with cisplatin and docetaxel (Italian phase II DOCETUX Study). Journal of Clinical Oncology. 26(15_suppl). 15605–15605. 3 indexed citations
12.
Fabio, Francesca Di, Carmine Pinto, Fabiola Lorena Rojas Llimpe, et al.. (2007). The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab. Gastric Cancer. 10(4). 221–227. 43 indexed citations
13.
Martoni, Andrea, S Tanneberger, & V. Mutri. (2007). Cancer Chemotherapy near the End of Life: The Time has come to set Guidelines for its Appropriate Use. Tumori Journal. 93(5). 417–422. 71 indexed citations
14.
15.
Pinto, Carmine, Francesca Di Fabio, Salvatore Siena, et al.. (2006). Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Annals of Oncology. 18(3). 510–517. 223 indexed citations
16.
Funaioli, C., Carmine Pinto, V. Mutri, et al.. (2006). Does Biomolecular Characterization of Stage II/III Colorectal Cancer Have Any Prognostic Value?. Clinical Colorectal Cancer. 6(1). 38–45. 12 indexed citations
17.
Pinto, Carmine, Francesca Di Fabio, Salvatore Siena, et al.. (2006). Phase II study of cetuximab plus FOLFIRI as first-line treatment in patients with unresectable/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (FOLCETUX study): Preliminary results. Journal of Clinical Oncology. 24(18_suppl). 4031–4031. 9 indexed citations
18.
Fabio, Francesco Di, Carmine Pinto, Stefano Fanti, et al.. (2005). Correlation between FDG-PET and pathologic response in patients with rectal cancer treated with neoadjuvant chemo-radiotherapy: First results of the Bologna Project. Journal of Clinical Oncology. 23(16_suppl). 3623–3623. 5 indexed citations
19.
20.
Pinto, Carmine, Francesca Sperandi, Antonella Marino, V. Mutri, & Andrea Martoni. (2005). P-421 Is prophylactic radiotherapy necessary asprevention of tumour seeding following thoracoscopy in malignant pleural mesothelioma (MPM)?. Lung Cancer. 49. S226–S226. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willemieke P.M. Dijksterhuis Breakdown of academic impact, for papers by M Canto Breakdown of academic impact, for papers by S. Pugh Breakdown of academic impact, for papers by Jenn Hian Koo Breakdown of academic impact, for papers by Lea Choung Wong Breakdown of academic impact, for papers by Shaesta Mehta Breakdown of academic impact, for papers by Elizabeth Won Breakdown of academic impact, for papers by Narayan Rajan Breakdown of academic impact, for papers by M Meehan Breakdown of academic impact, for papers by Jewel Samadder
Rankless by CCL
2026